Julian Berger

Scientist at Columbia University; Druckenmiller Fellow at The New York Stem Cell Foundation Research Institute

Julian Berger is a highly accomplished individual with a strong educational background in Biology, particularly Immunology and Genetics. He holds a Doctor of Philosophy (PhD) degree from Columbia University in the City of New York, focusing on Immunology and Genetics. Julian also completed his Bachelor of Arts degree at the University of Chicago, specializing in Biology, Immunology, and Cancer biology. He attended the Ramaz School for his early education.

Throughout his career, Julian has held various significant roles in esteemed organizations. He served as a Druckenmiller Fellow at The New York Stem Cell Foundation Research Institute, showcasing his expertise in stem cell research. Prior to this, Julian gained valuable experience as a Postdoctoral Researcher at Columbia University Irving Medical Center. During his academic journey, Julian worked as a PhD Student in the lab of Dr. Gerard Karsenty at Columbia University Medical Center, contributing to cutting-edge research in the field of biology.

In addition to his research endeavors, Julian has ventured into the finance sector, utilizing his scientific background in the role of a Biotech Equity Research Analyst. He has worked at reputable firms such as Aegis Capital Corp. and Morgan Joseph TriArtisan LLC, where he analyzed biotech companies and market trends to provide valuable insights for investors. Julian's multidisciplinary approach is further evident from his experience as a Researcher in labs led by distinguished scientists like Dr. Pete Savage at the University of Chicago and Dr. Jim Allison at Memorial Sloan Kettering Cancer Center. He also honed his skills as a Research Intern at the Polytechnic Institute of NYU under the mentorship of Richard Gross.

Julian Berger's diverse experiences encompass research, academia, and finance, reflecting his versatility and expertise in navigating different sectors. His contributions in stem cell research, biotech analysis, and cancer biology highlight his profound impact in advancing scientific knowledge and industry insights.